-
-
-
-
-
-
-
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
-
-
-
-
-
-
-
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
-
-
-
-
-
-
-
Pacira BioSciences Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
-
-
-
-
-
-
-
Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
-
-
-
-
-
-
-
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
-
-
-
-
-
-
-
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
-
100,013 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

